Articles

Factor VIII cross-matches to the human proteome reduce the predicted inhibitor risk in missense mutation hemophilia A

Blizard Institute, Barts and The London School of Medicine and Dentistry, QMUL, London;The Royal London Hospital Haemophilia Centre, Barts Health NHS Trust, London
Department of Biological Sciences and Institute of Structural and Molecular Biology, Birkbeck, University of London, UK
Blizard Institute, Barts and The London School of Medicine and Dentistry, QMUL, London;Department of Biological Sciences and Institute of Structural and Molecular Biology, Birkbeck, University of London, UK
Department of Biological Sciences and Institute of Structural and Molecular Biology, Birkbeck, University of London, UK
Department of Biological Sciences and Institute of Structural and Molecular Biology, Birkbeck, University of London, UK
Department of Biological Sciences and Institute of Structural and Molecular Biology, Birkbeck, University of London, UK
Department of Biological Sciences and Institute of Structural and Molecular Biology, Birkbeck, University of London, UK
Vol. 104 No. 3 (2019): March, 2019 https://doi.org/10.3324/haematol.2018.195669